![]() |
|
|

*
Nutrition Matters, Inc., Port Townsend, WA and
Division of Nutritional Sciences, University of Illinois at Urbana-Champaign, Urbana, IL
2To whom correspondence should be addressed.
| INTRODUCTION |
|---|
|
|
|---|
It is clear from the results presented and the discussions that took place during the symposium that with few exceptions, considerably more research is required before a good understanding of the health effects of soy can be realized. Perhaps the key point raised during this meeting was that most of the human studies conducted to date have been grossly underpowered. Consequently, some potentially clinically relevant physiologic effects may have been missed, and there is some lack of confidence about the validity of some of the effects that have been observed.
The symposium began just five days after the U.S. Food and Drug Administration formally approved a health claim for the cholesterol-lowering effect of soy protein. Several speakers presented findings on the hypocholesterolemic effects of soy protein. However, questions remain about the component or components of soy responsible for this effect; four speakers participated in a panel discussion on this issue, and each presented arguments in support of various components of soy. Clearly, more research is required to resolve this important matter.
Many participants at this meeting expressed some concern about the enthusiasm with which the food and supplement industries have promoted the hypothesized health benefits of soy foods. In addition, although most delegates considered soy foods to be absolutely safe, not all were in agreement on this point. Some expressed the opinion that for certain subsets of the population, such as infants and young children or women with estrogen receptorpositive tumors, soy foods could exert adverse effects. However, most concern was about soy (isoflavone) supplements, primarily because of the potential for excessive intake.
As occurs at all worthwhile scientific meetings, more questions were raised than answered. It appears, however, that with the number of investigators now actively involved in this field and with the enthusiasm that exists for the role that soy might play in reducing chronic disease risk, the next several years should go a long way toward providing critical insight into efficacy as well as safety.
The image of soy foods has come a long way since the early 1970s, when most Americans were either unfamiliar with these foods or believed them to be unappealing products consumed only by vegetarians. Surveys now suggest that Americans perceive soy as healthful and display a willingness to incorporate soy products into their diet. This is becoming easier as large, mainstream food and pharmaceutical companies enter the soy market. Thus, the scientific findings that will come from future research will have important public health implications.
Finally, this field owes a great deal to a select group of individuals who began working in this area through various endeavors more than 20 years ago. These pioneers were recognized for their outstanding contributions to increasing understanding and awareness of the health effects of soy foods and soybean constituents. Awards were presented to Herman Adlercreutz, University of Helsinki; Chai-Won Chung, Dr. Chungs Food Company (Korea); Cesare R. Sirtori, University of Milan; David Kritchevsky, Wistar Institute (Philadelphia); Doyle Waggle, Protein Technologies International (St. Louis) and Kenneth D. R. Setchell, Childrens Hospital (Cincinnati). The session on coronary heart disease was held in honor of the late Kenneth K. Carroll for his work on the cholesterol-lowering effects of soy protein.
| FOOTNOTES |
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||